Literature DB >> 8880498

Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae.

A Gori1, F Espinasse, A Deplano, C Nonhoff, M H Nicolas, M J Struelens.   

Abstract

The incidence and transmission patterns of extended-spectrum-beta-lactamase (ESBL)-producing Klebsiella pneumoniae in patients admitted to the intensive care unit (ICU) of a university hospital were investigated over a 3-year period. K. pneumoniae isolates were characterized by antibiotic susceptibility, capsular serotyping, plasmid profiles, and pulsed-field gel electrophoresis (PFGE) of genome macrorestriction patterns with XbaI, and the results were compared with those obtained by typing with the randomly amplified polymorphic DNA (RAPD) patterns. The discriminatory power of RAPD typing was evaluated for three primers. The incidence of isolation of ESBL-producing K. pneumoniae was 2.5 cases per 1,000 admissions to the ICU versus 0.35 cases per 1,000 admissions to other units (relative risk, 7.03; 95% confidence interval, 3.89 to 12.69). Infection developed in 53% of evaluable patients. Thirty-six percent of the cases were possibly acquired in other institutions. Isolates from ICU patients were subdivided into six capsular serotypes and into four clonal groups based on antibiotype, plasmid content, and PFGE and RAPD patterns. Two clones were associated with clusters of cross-infection, involving 5 and 12 patients, respectively. Following implementation of contact isolation precautions, the incidence of nosocomial acquisition of ESBL-producing K. pneumoniae decreased from 0.55 to 0.26 cases per 1,000 admissions (P = 0.03). PFGE and RAPD analysis showed concordant results and comparable discrimination for differentiation between groups of epidemiologically related strains of ESBL-producing K. pneumoniae. More subclonal variants were determined among epidemic clones by PFGE analysis than by RAPD analysis. Both methods are useful for typing K. pneumoniae strains in epidemiological investigations, although RAPD analysis is more efficient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880498      PMCID: PMC229291          DOI: 10.1128/jcm.34.10.2448-2453.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.

Authors:  G Arlet; M J Sanson-le Pors; M Rouveau; G Fournier; O Marie; B Schlemmer; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

2.  Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study.

Authors:  L Verbist
Journal:  Scand J Infect Dis Suppl       Date:  1991

3.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella enteritidis.

Authors:  A W Lin; M A Usera; T J Barrett; R A Goldsby
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

7.  Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital.

Authors:  C de Champs; D Sirot; C Chanal; M C Poupart; M P Dumas; J Sirot
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

8.  R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections.

Authors:  A Darfeuille-Michaud; C Jallat; D Aubel; D Sirot; C Rich; J Sirot; B Joly
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

9.  Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime.

Authors:  A P Johnson; M J Weinbren; B Ayling-Smith; S K Du Bois; S G Amyes; R C George
Journal:  J Hosp Infect       Date:  1992-02       Impact factor: 3.926

10.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.

Authors:  L Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  18 in total

1.  Pulsed-field gel electrophoresis in differentiation of erysipelothrix species strains.

Authors:  A T Okatani; T Uto; T Taniguchi; T Horisaka; T Horikita; K Kaneko; H Hayashidani
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.

Authors:  Salomon Ohana; Veronique Leflon; Esthel Ronco; Martin Rottman; Didier Guillemot; Sylvie Lortat-Jacob; Pierre Denys; Georges Loubert; Marie-Helène Nicolas-Chanoine; Jean-Louis Gaillard; Christine Lawrence
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.

Authors:  Suzanne Bialek; Jean-Philippe Lavigne; Jacqueline Chevalier; Estelle Marcon; Véronique Leflon-Guibout; Anne Davin; Richard Moreau; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

4.  Correlation of RAPD-PCR Profiles with ESBL Production in Clinical Isolates of Klebsiella pneumoniae in Tehran.

Authors:  Fereshteh Eftekhar; Parvaneh Nouri
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa.

Authors:  S Y Essack; L M Hall; D G Pillay; M L McFadyen; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Use of multienzyme multiplex PCR amplified fragment length polymorphism typing in analysis of outbreaks of multiresistant Klebsiella pneumoniae in an intensive care unit.

Authors:  Anneke van der Zee; Niels Steer; Eveline Thijssen; Jolande Nelson; Annemarie van't Veen; Anton Buiting
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.

Authors:  M Gniadkowski; A Palucha; P Grzesiowski; W Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.

Authors:  Monica Cartelle; Maria del Mar Tomas; Sonia Pertega; Alejandro Beceiro; M Angeles Dominguez; David Velasco; Francisca Molina; Rosa Villanueva; German Bou
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Epidemiology of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in a research colony of nonhuman primates.

Authors:  Robin L Burke; Chris A Whitehouse; Justin K Taylor; Edward B Selby
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.